Effects of HIV disease on lipid, glucose and insulin levels: Results from a large antiretroviral-naïve cohort

HIV Medicine

Volumn 6, Issue 2, 2005, Pages 114-121

  El Sadr, Wafaa M ^a,h   Mullin, C M ^b   Carr, A ^c   Gibert, C ^d   Rappoport, C ^e   Visnegarwala, F ^f   Grunfeld, C ^g   Raghavan, S S ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c ST VINCENT S HOSPITAL   (Australia)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h HARLEM HOSPITAL CENTER   (United States)

Author keywords

Antiretroviral naive; Glucose; HIV infection; Insulin; Lipids

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; STAGING; T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AFRICAN AMERICANS; AGE FACTORS; BLOOD GLUCOSE; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, VLDL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INSULIN; LIPIDS; MALE; REGRESSION ANALYSIS; RNA, VIRAL; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TRIGLYCERIDES;

EID: 15844412978     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2005.00273.x     Document Type: Article

References (31)

1. Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989; 86 (1): 27-31.
2. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992; 74 (5): 1045-52.
3. Kotler DP, Wang J, Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985; 42 (6): 1255-65.
4. Constans J, Pellegrin JL, Peuchant E, Dumon MF, Pellegrin I, Sergeant C et al. Plasma lipids in HIV-infected patients: a prospective study in 95 patients. Eur J Clin Invest 1994; 24 (6): 416-20.
5. Hommes MJ, Romijn JA, Endert E, Eeftinck Schattenkerk JK, Sauerwein HP. Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism 1991; 40 (6): 651-6.
6. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999; 353 (9170): 2093-9.
7. Dube MP, Johnson DL, Currier JS, Leedom JM. Protease inhibitor-associated hyperglycaemia. Lancet 1997; 350 (9079): 713-4.
8. Visnegarwala F, Krause KL, Musher DM. Severe diabetes associated with protease inhibitor therapy. Ann Intern Med 1997; 127 (10): 947.
9. Saint-Marc T, Partisani M, Poizot-Martin I, Rouviere O, Bruno F, Avellaneda R et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. Aids 2000; 14 (1): 37-49.
10. Safrin S, Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. Aids 1999; 13 (18): 2493-505.
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18 (6): 499-502.
12. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000; 23 (2): 171-5.
13. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996; 19 (10): 1138-41.
14. Hutchinson RG WR, Davis CE, Barnes R, Brown S, Romm F, Spencer JM, Tyroler HA, Wu K. Racial differences in risk factors for atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities. Angiology 1997 Apr; 48 (4): 279-90 1997.
15. Zoratti R. A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin? Eur J Epidemiol 1998; 14 (1): 9-21.
16. Cassel J, Heyen S, Bartel AG, Kaplan BH, Tyroler HA, Cornoni JC et al. Incidence of coronary heart disease by ethnic group, social class, and sex. Arch Intern Med 1971; 128 (6): 901-6.
17. Budoff MJ, Yang TP, Shavelle RM, Lamont DH, Brundage BH. Ethnic differences in coronary atherosclerosis. J Am Coll Cardiol 2002; 39 (3): 408-12.
18. Purnell JQ, Zambon A, Knopp RH, Pizzuti DJ, Achari R, Leonard JM et al. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects. Aids 2000; 14 (1): 51-7.
19. Noor MA, Lo JC, Mulligan K, Schwarz JM, Halvorsen RA, Schambelan M et al. Metabolic effects of indinavir in healthy HIV-seronegative men. Aids 2001; 15 (7): F11-8.
20. Riddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A et al. Impact of HIV infection and HAART on serum lipids in men. Jama 2003; 289 (22): 2978-82.
21. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987; 36 (4): 523-34.
22. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. Aids 1998; 12 (7): F51-8.
23. Behrens G, Dejam A, Schmidt H, Balks HJ, Brabant G, Korner T et al. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. Aids 1999; 13 (10): F63-70.
24. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition 1997; 13 (1): 65; discussion 64, 66..
25. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334 (15): 952-7.
26. Laws A RG. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med 1992 Jan; 231 (1): 25-30, Related Articles, Links 1992.
27. Henry K, Melroe H, Huebsch J, Hermundson J, Levine C, Swensen L et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998; 351 (9112): 1328.
28. Friedl AC, Affenhofer Jost CH, Schalcher C, Amann FW, Flepp M, Jenni R et al. Acceleration of confirmed coronary artery disease among HIV-infected patients on potent antiretroviral therapy. Aids 2000; 14 (17): 2790-2.
29. Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001; 32 (1): 130-9.
30. Friis-Moller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349 (21): 1993-2003.
31. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003; 348 (8): 702-10.